Compounds > orphenadrine

orphenadrine and metoclopramide

orphenadrine has been researched along with metoclopramide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ballerini, P; Bonmassar, E; Franchi, A; Fuschiotti, P; Piccioni, D1
Ballatori, E; Basurto, C; Minotti, V; Roila, F; Tonato, M1
Catalán Arlandis, JL; Jiménez Torres, NV1

Reviews

1 review(s) available for orphenadrine and metoclopramide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for orphenadrine and metoclopramide

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:6

    Topics: Animals; Antiemetics; Dacarbazine; Dexamethasone; Diazepam; Drug Therapy, Combination; Leukemia L1210; Male; Metoclopramide; Mice; Neoplasm Transplantation; Orphenadrine

1989
A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomiting.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:1

    Topics: Adult; Aged; Antiemetics; Chlorpromazine; Dexamethasone; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Orphenadrine

1986
Anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing chemotherapy.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:5

    Topics: Acute Disease; Age Factors; Antiemetics; Antineoplastic Agents; Body Weights and Measures; Chlorpromazine; Cisplatin; Cross-Sectional Studies; Dexamethasone; Drug Combinations; Humans; Logistic Models; Metoclopramide; Middle Aged; Multivariate Analysis; Ondansetron; Orphenadrine; Prognosis; Prospective Studies; Sex Factors; Vomiting

2000